Streetbeat News

Legal

FIVN

Rosen Law Firm has filed a class action lawsuit against Five9, Inc. for securities fraud, targeting investors who purchased securities between June 4, 2024, and August 8, 2024.

Portfolio Pulse from

December 11, 2024 | 1:00 am

HLFFF

The Schall Law Firm is investigating HelloFresh SE for potential securities fraud, focusing on whether the company issued misleading statements or failed to disclose important information to investors.

Portfolio Pulse from

December 11, 2024 | 1:00 am

BIOA

Levi & Korsinsky has initiated an investigation into BioAge Labs, Inc. (NASDAQ:BIOA) for potential federal securities law violations after the company halted its STRIDES Phase 2 trial due to safety concerns.

Portfolio Pulse from

December 11, 2024 | 1:00 am

LUV

Southwest Airlines Co is under investigation by The Schall Law Firm for potential securities fraud. The investigation is centered on whether the company issued false or misleading statements or failed to disclose important information to investors.

Portfolio Pulse from

December 11, 2024 | 1:00 am

PTVE

Pactiv Evergreen Inc. is under investigation by The Schall Law Firm for potential securities fraud and breaches of fiduciary duty by its directors and management. Investors are encouraged to contact the law firm.

Portfolio Pulse from

December 11, 2024 | 1:00 am

RTO

Levi & Korsinsky has filed a securities class action lawsuit on behalf of Rentokil Initial plc shareholders. Investors who suffered losses can seek potential recovery under federal securities laws.

Portfolio Pulse from

December 11, 2024 | 1:00 am

ASPI

The Law Offices of Howard G. Smith has announced a deadline for investors to file a lead plaintiff motion in a class action lawsuit against ASP Isotopes Inc. The deadline is February 3, 2025, and pertains to investors who purchased ASP Isotopes securities between October 30, 2024, and November 26, 2024.

Portfolio Pulse from

December 11, 2024 | 12:45 am

PACS

Levi & Korsinsky is inviting investors in PACS Group, Inc. to contact them before January 13, 2025, to discuss potential recovery options under federal securities laws due to investment losses.

Portfolio Pulse from

December 11, 2024 | 12:30 am

BIOA

BioAge Labs (BIOA) has halted its Phase 2 trial for azelaprag, raising concerns about pre-IPO disclosures. Hagens Berman is investigating and encourages investors with significant losses to contact them.

Portfolio Pulse from

December 11, 2024 | 12:30 am

ZETA

Levi & Korsinsky has announced a class action lawsuit against Zeta Global Holdings Corp. (NYSE:ZETA) with a lead plaintiff deadline of January 21, 2025. Investors who suffered losses are encouraged to seek potential recovery under federal securities laws.

Portfolio Pulse from

December 11, 2024 | 12:30 am